Heilsa Life Sciences Pvt. Ltd. – Global Leader in Injectable Manufacturing and Exports

Heilsa Life Sciences Pvt. Ltd., headquartered at 7 KM Milestones, Roorkee – Chandigarh Highway, Puhana Chowk, Roorkee – 247667, Haridwar, Uttarakhand, India, is a trusted name in the global pharmaceutical industry, renowned for its expertise in injectable manufacturing. With a WHO-GMP, GLP, and ISO-certified facility, we produce over 350 high-quality injectable molecules catering to diverse therapeutic needs, including anti-infectives, pain management, critical care, neurology, gastroenterology, and endocrinology. Our commitment to delivering affordable, reliable, and compliant pharmaceutical solutions has positioned us as a preferred partner for hospitals, distributors, and super stockists worldwide. By combining advanced technology, stringent quality controls, and efficient logistics, we ensure that our injectables reach healthcare providers across the globe with precision and speed. For inquiries, reach us at +91-9258237506 or via email at [Insert Email Here].

Our international operations focus on meeting the growing demand for quality injectables in key regions such as Africa, Southeast Asia, the Middle East, and Latin America. In Africa, we serve countries like Nigeria and Kenya, where healthcare systems rely on cost-effective solutions for critical care and nutritional therapies. In Nigeria, we supply hospitals in cities like Lagos, Abuja, and Kano with injectables such as Ceftriaxone, Artesunate, and Remdesivir, addressing the need for anti-infectives and critical care treatments. These cities, known for landmarks like Zuma Rock and the National Mosque, are hubs for healthcare innovation, and our products support their efforts to combat infectious diseases and emergencies. Similarly, in Kenya, we cater to markets in Nairobi, Mombasa, and Kisumu, providing Vitamin B12, Methylcobalamin, and Iron Sucrose injections to tackle nutritional deficiencies. With landmarks like Nairobi National Park and Maasai Mara, Kenya is a growing market for affordable pharmaceuticals, and we are proud to contribute to its healthcare landscape.

In Southeast Asia, Heilsa Life Sciences has established a strong presence in countries like the Philippines and Vietnam, where the demand for pain management and antibiotic injectables is on the rise. In the Philippines, we serve healthcare providers in Manila, Cebu, and Davao, supplying injectables like Tramadol and Dexamethasone for pain management and post-surgical care. These cities, home to landmarks such as Rizal Park and the Chocolate Hills, are key healthcare hubs where our products support hospitals and clinics in delivering quality care. In Vietnam, we cater to markets in Ho Chi Minh City, Hanoi, and Da Nang, offering antibiotics like Cefoperazone + Sulbactam and gastroenterology injectables like Pantoprazole. Known for cultural landmarks like Ha Long Bay and the Cu Chi Tunnels, Vietnam’s healthcare sector benefits from our reliable supply of injectables, ensuring timely availability for both urban and rural hospitals.

The Middle East is another critical region for our export operations, with a focus on countries like the United Arab Emirates (UAE) and Saudi Arabia. In the UAE, we supply wellness and hormonal therapy injectables such as Glutathione, Vitamin D3, and HCG to cities like Dubai, Abu Dhabi, and Sharjah. These cities, famous for landmarks like Burj Khalifa and Sheikh Zayed Grand Mosque, have a growing demand for high-quality pharmaceuticals to support their advanced healthcare infrastructure. In Saudi Arabia, our injectables like Enoxaparin and Noradrenaline cater to critical care needs in cities such as Riyadh, Jeddah, and Dammam, which are known for landmarks like Al Masmak Fortress and Kingdom Centre Tower. Our WHO-GMP certification ensures that our products meet the stringent regulatory requirements of the Middle East, making us a trusted partner for distributors and hospitals in the region.

In Latin America, Heilsa Life Sciences serves countries like Brazil and Mexico, where chronic disease management and critical care are key priorities. In Brazil, we supply injectables like Insulin, Hydrocortisone, and Mannitol to cities such as São Paulo, Rio de Janeiro, and Brasília, supporting the treatment of diabetes, inflammation, and emergency care. These cities, home to iconic landmarks like Christ the Redeemer and Iguazu Falls, are major healthcare markets where our products help address the needs of a diverse population. In Mexico, we provide injectables such as Ondansetron, Paracetamol, and Anti-D to hospitals in Mexico City, Guadalajara, and Monterrey, which are known for landmarks like Chichen Itza and Teotihuacan Pyramids. Our focus on quality and affordability ensures that healthcare providers in Latin America can rely on us for consistent supplies of essential injectables.

Our global operations are supported by a robust framework that includes export manufacturing, regulatory compliance, and efficient logistics. From our Roorkee facility, we produce injectables in bulk, adhering to international standards like USFDA and EU-GMP, ensuring compliance with the regulatory requirements of each target country. We partner with reliable shipping networks to deliver our products on time, whether to a hospital in Lagos, a distributor in Dubai, or a super stockist in São Paulo. Additionally, we offer third-party manufacturing and custom formulation services, allowing international clients to tailor products to their specific needs. By maintaining competitive pricing and a diverse portfolio, Heilsa Life Sciences continues to make a significant impact on global healthcare, delivering life-saving injectables to those who need them most.